TrialClinical pharmacology in drug development2021

A Randomized, Single-Blind, Placebo-Controlled, 3-Way Crossover Study to Evaluate the Effect of Therapeutic and Supratherapeutic Doses of Edaravone on QT/QTc Interval in Healthy Subjects.

Hidetoshi Shimizu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.